Article info

Download PDFPDF

Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease

Authors

  1. Correspondence to Dr Ryo Kubota, President, Kubota Vision Inc, Seattle, WA 98101-4174, USA; rkubota{at}kubotavision.com
View Full Text

Citation

Kubota R, Birch DG, Gregory JK, et al
Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease

Publication history

  • Received August 11, 2020
  • Revised September 26, 2020
  • Accepted October 30, 2020
  • First published November 19, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.